According to ReWalk Robotics's latest financial reports the company has $28.08 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $28.08 M | -58.64% |
2022-12-31 | $67.89 M | -23.14% |
2021-12-31 | $88.33 M | 334.09% |
2020-12-31 | $20.35 M | 25.21% |
2019-12-31 | $16.25 M | 70.26% |
2018-12-31 | $9.54 M | -34.47% |
2017-12-31 | $14.56 M | -38.48% |
2016-12-31 | $23.67 M | 32.51% |
2015-12-31 | $17.86 M | -57.28% |
2014-12-31 | $41.82 M | 372.11% |
2013-12-31 | $8.86 M | 1052.15% |
2012-12-31 | $0.76 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Abiomed ABMD | $0.82 B | 2,821.24% | ๐บ๐ธ USA |
Hologic HOLX | $1.93 B | 6,779.96% | ๐บ๐ธ USA |
ResMed RMD | $0.21 B | 648.66% | ๐บ๐ธ USA |
Nevro
NVRO | $0.32 B | 1,049.18% | ๐บ๐ธ USA |